John Fraunces | LifeSci Advisors |
Dave Domzalski | President and Chief Executive Officer |
Tyler Zeronda | Chief Financiial Officer |
Iain Stuart | Chief Scientific Officer |
David Amsellem | Piper Sandler |
Carvey Leung | Cantor Fitzgerald |
Patrick Dolezal | LifeSci Capital |
Good morning and welcome to the VYNE Therapeutics conference call to discuss the Third Quarter 2021 financial results and corporate update. At this time, all participants are on listen-only mode. And following the Company's formal remarks, we will open the call for your questions. Please be advised that this call is being recorded at the Company's request. I will now turn the call over to John Fraunces of LifeSci Advisors.